Kocsis L - Search Results

1

Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel.

Podolski-Renić A, Bősze S, Dinić J, Kocsis L, Hudecz F, Csámpai A, Pešić M. Podolski-Renić A, et al. Among authors: kocsis l. Metallomics. 2017 Aug 16;9(8):1132-1141. doi: 10.1039/c7mt00183e. Metallomics. 2017. PMID: 28737782

2

Synthesis, structure and in vitro cytostatic activity of ferrocene-Cinchona hybrids.

Kocsis L, Szabó I, Bősze S, Jernei T, Hudecz F, Csámpai A. Kocsis L, et al. Bioorg Med Chem Lett. 2016 Feb 1;26(3):946-949. doi: 10.1016/j.bmcl.2015.12.059. Epub 2015 Dec 18. Bioorg Med Chem Lett. 2016. PMID: 26739780 Free article.

3

Nociceptin antagonism: probing the receptor by N-acetyl oligopeptides.

Kocsis L, Orosz G, Magyar A, Al-Khrasani M, Kató E, Rónai AZ, Bes B, Meunier JC, Gündüz O, Tóth G, Borsodi A, Benyhe S. Kocsis L, et al. Regul Pept. 2004 Nov 15;122(3):199-207. doi: 10.1016/j.regpep.2004.06.019. Regul Pept. 2004. PMID: 15491792

4

The effect of peptide length on the cleavage kinetics of 2-chlorotrityl resin-bound ethers.

Kocsis L, Ruff F, Orosz G. Kocsis L, et al. J Pept Sci. 2006 Jun;12(6):428-36. doi: 10.1002/psc.745. J Pept Sci. 2006. PMID: 16485312

5

Partial and full agonism in endomorphin derivatives: comparison by null and operational model.

Rónai AZ, Al-Khrasani M, Benyhe S, Lengyel I, Kocsis L, Orosz G, Tóth G, Kató E, Tóthfalusi L. Rónai AZ, et al. Among authors: kocsis l. Peptides. 2006 Jun;27(6):1507-13. doi: 10.1016/j.peptides.2005.12.003. Epub 2006 Jan 18. Peptides. 2006. PMID: 16413634

6

In vitro binding and functional studies of Ac-RYYRIK-ol and its derivatives, novel partial agonists of the nociceptin/orphanin F/Q receptor.

Gunduz O, Sipos F, Spagnolo B, Kocsis L, Magyar A, Orosz G, Borsodi A, Calò G, Benyhe S. Gunduz O, et al. Among authors: kocsis l. Neurosignals. 2006-2007;15(2):91-101. doi: 10.1159/000094743. Epub 2006 Jul 26. Neurosignals. 2006. PMID: 16874009 Free article.

7

Endomorphin synthesis in rat brain from intracerebroventricularly injected [3H]-Tyr-Pro: a possible biosynthetic route for endomorphins.

Rónai AZ, Szemenyei E, Kató E, Kocsis L, Orosz G, Al-Khrasani M, Tóth G. Rónai AZ, et al. Among authors: kocsis l. Regul Pept. 2006 Mar 15;134(1):54-60. doi: 10.1016/j.regpep.2005.12.004. Epub 2006 Feb 7. Regul Pept. 2006. PMID: 16464510

8

Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy.

Al-Khrasani M, Orosz G, Kocsis L, Farkas V, Magyar A, Lengyel I, Benyhe S, Borsodi A, Rónai AZ. Al-Khrasani M, et al. Among authors: kocsis l. Eur J Pharmacol. 2001 Jun 1;421(1):61-7. doi: 10.1016/s0014-2999(01)01014-7. Eur J Pharmacol. 2001. PMID: 11408050

9

Side chain modifications change the binding and agonist properties of endomorphin 2.

Lengyel I, Orosz G, Biyashev D, Kocsis L, Al-Khrasani M, Rónai A, Tömböly C, Fürst Z, Tóth G, Borsodi A. Lengyel I, et al. Among authors: kocsis l. Biochem Biophys Res Commun. 2002 Jan 11;290(1):153-61. doi: 10.1006/bbrc.2001.6136. Biochem Biophys Res Commun. 2002. PMID: 11779147

10

In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.

Gündüz O, Rizzi A, Baldisserotto A, Guerrini R, Spagnolo B, Gavioli EC, Kocsis L, Magyar A, Benyhe S, Borsodi A, Calò G. Gündüz O, et al. Among authors: kocsis l. Eur J Pharmacol. 2006 Jun 6;539(1-2):39-48. doi: 10.1016/j.ejphar.2006.03.075. Epub 2006 Apr 5. Eur J Pharmacol. 2006. PMID: 16682024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters